Novel Dengue Virus NS2B/NS3 Protease Inhibitors

Dengue fever is a severe, widespread, and neglected disease with more than 2 million diagnosed infections per year. The dengue virus NS2B/NS3 protease (PR) represents a prime target for rational drug design. At the moment, there are no clinical PR inhibitors (PIs) available. We have identified diary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Wu, Hongmei, Bock, Stefanie, Snitko, Mariya, Berger, Thilo, Weidner, Thomas, Holloway, Steven, Kanitz, Manuel, Diederich, Wibke E., Steuber, Holger, Walter, Christof, Hofmann, Daniela, Weißbrich, Benedikt, Spannaus, Ralf, Acosta, Eliana G., Bartenschlager, Ralf, Engels, Bernd, Schirmeister, Tanja, Bodem, Jochen
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335830/
https://ncbi.nlm.nih.gov/pubmed/25487800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03543-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados